Holds one active US DMF and 2 valid CEPs for propranolol, filing since 2002. Its 2025 FDA inspection closed as VAI, and its GMP is recognised in 19 markets.
Holds 2 active US DMFs and one valid CEP for propranolol, filing since 2021. Its 2025 FDA inspection closed as VAI, and its GMP is recognised in 14 markets.
Holds one active US DMF for propranolol, filing since 2024. Its 2024 FDA inspection closed as VAI, and its GMP is recognised in 29 markets.
Holds 2 active US DMFs for propranolol, filing since 2024. Its 2025 FDA inspection closed as NAI, and its GMP is recognised in 1 market.
Holds one active US DMF for propranolol, filing since 2025. Its 2025 FDA inspection closed as NAI.
This page filters the worldwide Propranolol manufacturer list to companies based in India. The order is set by active filings weighted by regulator, inspection outcomes and their recency, breadth of GMP recognition, and evidence of real exports, less any open risk flags. Read the full method.
Ask Fred which manufacturers are on record for propranolol and what filings they hold.
Chat with Fred, your AI analyst